Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.0K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term incidence and progression of vision-threatening diabetic retinopathy in Asian populations.

Journal of global health·2026
Same author

Natural history of glaucoma suspects in a tertiary eye centre in Singapore.

Eye (London, England)·2026
Same author

Multi-Marker Detection of Diabetic Kidney Disease and Risk of Incident Diabetic Retinopathy in a Multi-Ethnic Asian Population.

Diagnostics (Basel, Switzerland)·2026
Same author

Pattern of association between school grades and myopia: longitudinal findings from the SCORM cohort.

Eye (London, England)·2026
Same author

Retinal biological age correlates with bone mineral density and fracture risk score and predicts incident osteoporosis.

PLOS digital health·2026
Same author

Comparative effectiveness of first-line targeted therapies in ALK-positive non-small cell lung cancer: real-world evidence of tyrosine kinase inhibitors.

Lung cancer (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Nov 1, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K

Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment.

Eva K Fenwick1,2, Semra Ozdemir2, Ryan E K Man1,2

  • 1Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

JAMA Ophthalmology
|June 24, 2021
PubMed
Summary

A new Glaucoma Utility Instrument (Glau-U) shows significant utility decrements in advanced glaucoma. This tool aids cost-effectiveness analyses for glaucoma treatments and vision loss interventions.

More Related Videos

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

635
Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
05:14

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter

Published on: September 16, 2025

262

Related Experiment Videos

Last Updated: Nov 1, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

635
Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
05:14

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter

Published on: September 16, 2025

262

Area of Science:

  • Ophthalmology
  • Health Economics
  • Psychometrics

Background:

  • A validated instrument for estimating glaucoma-specific utilities across disease severity is needed for cost-effectiveness analyses.
  • Current methods lack a glaucoma-specific tool to assess treatment cost-effectiveness.

Purpose of the Study:

  • To develop and validate the Glaucoma Utility Instrument (Glau-U).
  • To assess the association between Glau-U utilities and glaucoma severity and vision impairment.

Main Methods:

  • A cross-sectional study involving discrete choice experiment (DCE) surveys.
  • Glau-U development included 6 quality-of-life attributes.
  • Mixed logit regression and ANOVA were used to determine utility weights and analyze associations.

Main Results:

  • Glau-U utilities significantly decreased with increasing glaucoma severity and vision impairment.
  • Large utility decrements were observed in advanced glaucoma stages (up to 76.1% reduction).
  • Glau-U utilities showed moderate correlations with visual field data and low correlations with EQ-5D utilities.

Conclusions:

  • The Glaucoma Utility Instrument (Glau-U) is a validated tool for assessing glaucoma-specific utilities.
  • Glau-U is useful for cost-effectiveness analyses of glaucoma interventions.
  • Findings support Glau-U's utility in informing resource allocation for vision loss.